- We will not be sold to BP in the near future.
- ‘waiting’ 3 months from approval to sales in January is not stalling, that’s a quick turnaround from approval to sales. Think about how complex that task is.
- I think the Euroz analysis forecasts a loss on the first year of sales, it’s not skyrocketing overnight.
- There is statistically a 10% chance we won’t get FDA approval.
- There will be no dividends for a looong time, if ever.
- I am as confident as ever of success, despite the above. Not trying to be a downer, just a realist.
Go BOT, keep it in perspective and enjoy the ups (and downs)
Ann: Appointment of Dr Howie McKibbon as CEO, page-61
-
- There are more pages in this discussion • 91 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.0¢ |
Change
-0.010(2.70%) |
Mkt cap ! $654.2M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.0¢ | 34.5¢ | $2.959M | 8.301M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 74186 | 36.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.5¢ | 422090 | 8 |
View Market Depth
| Last trade - 16.10pm 15/10/2024 (20 minute delay) ? |
| BOT (ASX) Chart |